Autonomix Medical, Common Stock EBITDA

AMIX Stock   6.28  7.24  53.55%   
Autonomix Medical, Common fundamentals help investors to digest information that contributes to Autonomix Medical,'s financial success or failures. It also enables traders to predict the movement of Autonomix Stock. The fundamental analysis module provides a way to measure Autonomix Medical,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Autonomix Medical, stock.
Last ReportedProjected for Next Year
EBITDA-15.3 M-14.5 M
EBITDA is likely to rise to about (14.5 M) in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Autonomix Medical, Common Company EBITDA Analysis

Autonomix Medical,'s EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Autonomix Medical, EBITDA

    
  (15.27 M)  
Most of Autonomix Medical,'s fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Autonomix Medical, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Autonomix EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Autonomix Medical, is extremely important. It helps to project a fair market value of Autonomix Stock properly, considering its historical fundamentals such as EBITDA. Since Autonomix Medical,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Autonomix Medical,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Autonomix Medical,'s interrelated accounts and indicators.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

Autonomix Ebitda

Ebitda

(14.5 Million)

Autonomix Medical, reported EBITDA of (15.27 Million) in 2023
According to the company disclosure, Autonomix Medical, Common reported earnings before interest,tax, depreciation and amortization of (15.27 Million). This is 101.74% lower than that of the Health Care Equipment & Supplies sector and 102.38% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.39% higher than that of the company.

Autonomix EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Autonomix Medical,'s direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Autonomix Medical, could also be used in its relative valuation, which is a method of valuing Autonomix Medical, by comparing valuation metrics of similar companies.
Autonomix Medical, is currently under evaluation in ebitda category among its peers.

Autonomix Fundamentals

About Autonomix Medical, Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Autonomix Medical, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Autonomix Medical, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Autonomix Medical, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Autonomix Stock Analysis

When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.